dc.contributor.author | Gogus, F | |
dc.contributor.author | Fresko, I | |
dc.contributor.author | Mat, C | |
dc.contributor.author | Uysal, O | |
dc.contributor.author | Yurdakul, Sebahattin | |
dc.contributor.author | Uysal, S | |
dc.contributor.author | Ozyazgan, Yılmaz | |
dc.contributor.author | Yazici, Hasan | |
dc.date.accessioned | 2021-03-03T18:15:10Z | |
dc.date.available | 2021-03-03T18:15:10Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., Fresko I., Yazici H., "A double-blind trial of depot corticosteroids in Behcet's syndrome", RHEUMATOLOGY, cilt.45, sa.3, ss.348-352, 2006 | |
dc.identifier.issn | 1462-0324 | |
dc.identifier.other | av_4e10e145-a159-4876-a673-151886628582 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/55772 | |
dc.identifier.uri | https://doi.org/10.1093/rheumatology/kei165 | |
dc.description.abstract | Objectives. Corticosteroids are widely used in Behcet's syndrome despite the absence of controlled studies. We assessed the effect of depot corticosteroids primarily for genital ulcers and secondarily for the other mucocutaneous manifestations of Behcet's syndrome. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | ROMATOLOJİ | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | İç Hastalıkları | |
dc.title | A double-blind trial of depot corticosteroids in Behcet's syndrome | |
dc.type | Makale | |
dc.relation.journal | RHEUMATOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 45 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 348 | |
dc.identifier.endpage | 352 | |
dc.contributor.firstauthorID | 6633 | |